Is metabolic syndrome a risk factor for carotid atherosclerosis in normotensive and prehypertensive individuals?

Journal of Atherosclerosis and Thrombosis

Volumn 14, Issue 2, 2007, Pages 72-77

  Ishizaka, Nobukazu ^a   Ishizaka, Yuko ^b   Toda, Ei Ichi ^b   Nagai, Ryozo ^a   Yamakado, Minoru ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b MITSUI MEMORIAL HOSPITAL   (Japan)

Author keywords

Carotid artery; Metabolic syndrome; Normotension; Prehypertension

Indexed keywords

ADULT; AGE; AGED; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE; CAROTID ARTERY; CLINICAL TRIAL; FEMALE; HUMAN; INTIMA; JAPAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; RISK FACTOR; SEX DIFFERENCE; TUNICA MEDIA;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; BLOOD PRESSURE; CAROTID ARTERIES; FEMALE; HUMANS; JAPAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTORS; SEX FACTORS; TUNICA INTIMA; TUNICA MEDIA;

EID: 34250625257     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.14.72     Document Type: Article

References (22)

1. Sattar N, Gaw A, Scherbakova O, Ford I, O'Reilly DS, Haffner SM, Isles C, Macfarlane PW, Packard CJ, Cobbe SM, and Shepherd J: Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation, 2003; 108:414-419
2. Ninomiya. JK, L'Italien G, Criqui MH, Whyte JL, Gamst A, and Chen RS: Association of the metabolic syndrome with history of myocardial infarction and stroke in the third national health and nutrition examination survey. Circulation, 2004; 109:42-46
3. Ishizaka N, Ishizaka Y, Toda E, Nagai R, and Yamakado M: Association between serum uric acid, metabolic syndrome, and carotid atherosclerosis in Japanese individuals. Arte- rioscler Thromb Vasc Biol, 2005; 25:1038-1044
4. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. J Hypertens, 1999; 17:151-183
5. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). Jama, 2001; 285:2486-2497
6. Matsuzawa Y: Metabolic syndrome-definition and diagnostic criteria in Japan. J Atheroscler Thromb, 2005; 12:301
7. Bruno G, Merletti F, Biggeri A, Bargero G, Ferrero S, Runzo C, Prina Cerai S, Pagano G, and Cavallo-Perin P: Metabolic syndrome as a predictor of all-cause and cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study. Diabetes Care, 2004; 27:2689-2694
8. Costa LA, Canani LH, Lisboa HR, Tres GS, and Gross JL: Aggregation of features of the metabolic syndrome is associated with increased prevalence of chronic complications in Type 2 diabetes. Diabet Med, 2004; 21:252-255
9. Schillaci G, Pirro M, Vaudo G, Gemelli F, Marchesi S, Porcellati C, and Mannarino E: Prognostic value of the metabolic syndrome in essential hypertension. J Am Coll Cardiol, 2004; 43:1817-1822
10. Ishizaka N, Ishizaka Y, Toda E, Hashimoto H, Nagai R, and Yamakado M: Hypertension is the most common component of metabolic syndrome and the greatest contributor to carotid arteriosclerosis in apparently healthy Japanese individuals. Hypertens Res, 2005; 28:27-34
11. Ishizaka N, Ishizaka Y, Hashimoto H, Toda. E, Nagai R, and Yamakado M: Metabolic syndrome may not associate with carotid plaque in subjects with optimal, normal, or high-normal blood pressure. Hypertension 2006; 48:411-417
12. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, and Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 1985; 28:412-419
13. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jr., Jones DW, Materson BJ, Oparil S, Wright JT, Jr., and Roccella EJ: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. Jama, 2003; 289:2560-2572
14. Handa N, Matsumoto M, Maeda H, Hougaku H, and Kamada T: Ischemic stroke events and carotid atherosclerosis. Results of the Osaka Follow-up Study for Ultrasonographic Assessment of Carotid Atherosclerosis (the OSACA Study). Stroke, 1995; 26:1781-1786
15. Ishizaka N, Ishizaka Y, Toda E, Hashimoto H, Nagai R, and Yamakado M: Association between cigarette smoking, metabolic syndrome, and carotid arteriosclerosis in Japanese individuals. Atherosclerosis, 2005; 181:381-388
16. Arai H, Yamamoto A, Matsuzawa Y, Saito Y, Yamada N, Oikawa S, Mabuchi H, Teramoto T, Sasaki J, Nakaya N, Itakura H, Ishikawa Y, Ouchi Y, Horibe H, Shirahashi N, and Kita T: Prevalence of metabolic syndrome in the general Japanese population in 2000. J Atheroscler Thromb, 2006; 13:202-208
17. Tanaka H, Shimabukuro T, and Shimabukuro M: High prevalence of metabolic syndrome among men in Okinawa. J Atheroscler Thromb, 2005; 12:284-288
18. Kuzuya M, Ando F, Iguchi A, and Shimokata H: Age-specific change of prevalence of metabolic syndrome: Longitudinal observation of large Japanese cohort. Atherosclerosis, 2006
19. Miyatake N, Kawasaki Y, Nishikawa H, Takenami S, and Numata T: Prevalence of metabolic syndrome in Okayama prefecture, Japan. Intern Med, 2006; 45:107-108
20. Mancia G, Parati G, Borghi C, Ghironzi G, Andriani E, Marinelli L, Valentini M, Tessari F, and Ambrosioni E: Hypertension prevalence, awareness, control and association with metabolic abnormalities in the San Marino population: the SMOOTH study. J Hypertens, 2006; 24:837-843
21. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med, 1997; 157:2413-2446
22. Kanauchi M, Kanauchi K, Hashimoto T, and Saito Y: Metabolic syndrome and new category 'pre-hypertension' in a Japanese population. Curr Med Res Opin, 2004; 20:1365-1370